Skip to content

Clinical trials

Leiomyosarcoma trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leiomyosarcoma Country / region: Italy Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20142
20151
20172
20191
20212
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting3
Active, not recruiting2
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC3
Grupo Espanol de Investigacion en Sarcomas2
Italian Sarcoma Group2
Advenchen Laboratories, LLC1
Eli Lilly and Company1
Mario Negri Institute for Pharmacological Research1
PTC Therapeutics1
PharmaMar1
Pierre Fabre Medicament1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leiomyosarcoma13
Liposarcoma7
Sarcoma7
Histiocytoma, Malignant Fibrous4
Sarcoma, Synovial4
Hemangiosarcoma3
Sarcoma, Alveolar Soft Part3
Fibrosarcoma2
Bone Neoplasms1
Chondrosarcoma1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.